Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Lymphedema 1Disease 1

Interventions

Mammography 4Magnetic Resonance Spectroscopy 3pembrolizumab 1Vertical Dimension 1Therapeutics 1TKM-080301 1Surveys and Questionnaires 1Sensitivity Training Groups 1Self-Management 1Referral and Consultation 1Quality of Life 1Professional Autonomy 1Patient Positioning 1Paclitaxel 1Methylene Blue 1Mass Screening 1Magnetic Resonance Imaging 1Interviews as Topic 1Interleukin-15 1Gemcitabine 1Exercise 1Drug Delivery Systems 1Doxorubicin 1Counseling 1Blood Specimen Collection 1Biopsy 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Methylene Blue × Breast × Clear all
NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed
62 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡